Results 41 to 50 of about 168,406 (311)

Perventricular Device Closure of Native Congenital Muscular Ventricular Septal Defects in Small Infants   $\hspace{0.17em}$ ≤ 5 kg: Single‐Center Study of the Risk Factors for Failure of the Intervention and Non‐Optimal Outcome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background and Aims Perventricular device closure of muscular VSD in small infants is a less invasive option than surgical closure under cardiopulmonary bypass and offers better outcomes than palliative pulmonary artery banding. However, the specific risk factors that could affect procedural success and optimal outcomes have not been ...
Emine Hekim Yilmaz, Ilker Kemal Yucel, Murat Surucu, Huseyin Karadag, Ibrahim Halil Demir, Murat Cicek, Numan Ali Aydemir, Ahmet Celebi   +7 more
wiley   +1 more source

Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?

Current Controlled Trials in Cardiovascular Medicine, 2000
Thrombolysis and primary angioplasty are both recommended reperfusion strategies for elderly patients presenting with myocardial infarction (MI). Primary angioplasty is most beneficial in high-risk patients. While the elderly have a high absolute risk of
White Harvey D
doaj   +1 more source

Repeat coronary angioplasty

Journal of the American College of Cardiology, 1984
The potential of repeat percutaneous transluminal coronary angioplasty as a mode of therapy for recurrence of stenosis after initially successful angioplasty was examined on the basis of data on all 514 patients with successful angioplasty at Emory University before April 1982. Recurrence was found in 171 (33%) of the 514 patients.
John S. Douglas, Rose Tankersley, Spencer B. King, Bernhard Meier, Andreas R. Gruentzig, Kathy Galan, Jay Hollman, Thomas Ischinger   +7 more
openaire   +2 more sources

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2015
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but potentially life-threatening disease of the pulmonary circulation [1]. The pathogenesis of CTEPH is not entirely clear.
M. Kurzyna, Szymon Darocha, Andrzej Koteja, R. Pietura, A. Torbicki   +4 more
semanticscholar   +1 more source

The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug‐Coated Balloon Angioplasty

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Initially, drug‐coated balloon (DCB) angioplasty was primarily employed for in‐stent restenosis (ISR) treatment. Over time, its indications have broadened to include de novo small‐vessel lesions and bifurcation lesions. However, there is a lack of effective strategies to reduce restenosis rates post‐DCB angioplasty.
Chenhang Wang, Li Chen, Xiaoyong Xu
wiley   +1 more source

Distal protection devices during percutaneous coronary and carotid interventions

Current Controlled Trials in Cardiovascular Medicine, 2001
Distal embolization of particulate matter complicates percutaneous coronary and peripheral interventions more often than had been recognized until recently. A number of distal protection devices are under development.
Berger Peter B, Denktas Ali E, Orford James L, Fasseas Panayotis   +3 more
doaj   +1 more source

Carotid Angioplasty: Is It Safe?

Journal of Endovascular Surgery, 1996
For 15 years, balloon angioplasty has been cautiously applied to carotid artery occlusive lesions. Procedural results have, by and large, been satisfactory, but the potential for significant neurologic complications and a dearth of controlled studies with long-term follow-up have impeded the development of carotid angioplasty until recently.
P. Qvarfordt, Jean-Pierre Becquemin, Yves Castier, Didier Mellière   +3 more
openaire   +3 more sources

Impact of Femoropopliteal Drug‐Coated Balloon Use on Clinical Outcomes in Patients With Chronic Limb‐Threatening Ischemia

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane, Yosuke Hata, Osamu Iida, Yasunori Ueda, Kuniyasu Ikeoka, Taku Toyoshima, Motoki Yasunaga, Hiroaki Nohara, Akito Kawamura, Sho Nakao, Yohei Sotomi, Yasushi Sakata   +11 more
wiley   +1 more source

Safety of balloon angioplasty for symptomatic intracranial artery stenosis

Chinese Journal of Contemporary Neurology and Neurosurgery, 2019
Objective A recent randomized controlled trial suggested that aggressive medical management was superior to angioplasty for symptomatic intracranial artery stenosis. But it still had its flaws.
Yu-jie SUN, Guang-wen LI, Ying-gao LIU, Peng LIU, Wen-tao GONG, Xian-jun ZHANG, Jian DING, Hong-xia WANG, Nai-dong WANG, Yong ZHANG   +9 more
doaj  

Cost‐Utility Analysis of Different Treatment Modalities in Patients Undergoing Percutaneous Coronary Intervention: Thai PCI Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Cost‐utility analyses of percutaneous coronary interventions (PCIs) provide valuable insights into the economic value of these procedures. However, data is lacking, particularly in developing countries with limited resources. Aims This analysis aimed to compare the cost‐utility of different treatment modalities used for PCI patients
Oraluck Pattanaprateep, Thosaphol Limpijankit, Thunyarat Anothaisintawee, Sukanya Siriyotha, Nakarin Sansanayudh, Ammarin Thakkinstian   +5 more
wiley   +1 more source